跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xyveemox - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xyveemox
Approved
STANDARD
Xyveemox
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7f8187f119fb6920
Company
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Type
Standard
Approval Details
Approval Id
7f8187f119fb6920
Drug Approval Philippines Name
Xyveemox
Product Name
Xyveemox
Registration Number
DRP-2645-02
Brand Name
Xyveemox
Generic Name
Co-Amoxiclav
Dosage Form
Film-Coated Tablet
Dosage Strength
625 mg
Manufacturer
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Importer
Sahar International Trading, Inc.
Distributor
AMSON PHARMACEUTICALS
Company Detail Path
/organization/cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd
Issuance Date
24 August 2021
Expiry Date
18 June 2026
Pharmacologic Category
Antibacterial (Penicillin/Beta-Lactamase Inhibitor combination)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7f8187f119fb6920
Type
Standard
Back to Philippines FDA Approvals